Cargando…
STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262938/ https://www.ncbi.nlm.nih.gov/pubmed/35798713 http://dx.doi.org/10.1038/s41392-022-01050-7 |
| _version_ | 1784742614587670528 |
|---|---|
| author | Wang, Ran Cai, Jianghong Chen, Keyuan Zhu, Menglin Li, Zhaoyi Liu, Hua Liu, Tiantian Mao, Jianchun Ding, Qian Zhu, Yi Zhun |
| author_facet | Wang, Ran Cai, Jianghong Chen, Keyuan Zhu, Menglin Li, Zhaoyi Liu, Hua Liu, Tiantian Mao, Jianchun Ding, Qian Zhu, Yi Zhun |
| author_sort | Wang, Ran |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9262938 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92629382022-07-09 STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway Wang, Ran Cai, Jianghong Chen, Keyuan Zhu, Menglin Li, Zhaoyi Liu, Hua Liu, Tiantian Mao, Jianchun Ding, Qian Zhu, Yi Zhun Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-07-08 /pmc/articles/PMC9262938/ /pubmed/35798713 http://dx.doi.org/10.1038/s41392-022-01050-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Wang, Ran Cai, Jianghong Chen, Keyuan Zhu, Menglin Li, Zhaoyi Liu, Hua Liu, Tiantian Mao, Jianchun Ding, Qian Zhu, Yi Zhun STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway |
| title | STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway |
| title_full | STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway |
| title_fullStr | STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway |
| title_full_unstemmed | STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway |
| title_short | STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway |
| title_sort | stat3-nav2 axis as a new therapeutic target for rheumatoid arthritis via activating ssh1l/cofilin-1 signaling pathway |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262938/ https://www.ncbi.nlm.nih.gov/pubmed/35798713 http://dx.doi.org/10.1038/s41392-022-01050-7 |
| work_keys_str_mv | AT wangran stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway AT caijianghong stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway AT chenkeyuan stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway AT zhumenglin stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway AT lizhaoyi stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway AT liuhua stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway AT liutiantian stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway AT maojianchun stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway AT dingqian stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway AT zhuyizhun stat3nav2axisasanewtherapeutictargetforrheumatoidarthritisviaactivatingssh1lcofilin1signalingpathway |